The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Adler, L. A.
* Articles by Angrist, B.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Adler, L. A.
* Articles by Angrist, B.

Am J Psychiatry 1993; 150:1405-1407
Copyright © 1993 by American Psychiatric Association


BRIEF REPORTS

Vitamin E treatment of tardive dyskinesia

LA Adler, E Peselow, J Rotrosen, E Duncan, M Lee, M Rosenthal and B Angrist
Psychiatry Service, New York Department of Veterans Affairs Medical Center, NY 10010.

OBJECTIVE: The authors studied the effects of vitamin E treatment of tardive dyskinesia; earlier studies have produced contradictory results. METHOD: Twenty-eight patients with tardive dyskinesia were treated in a double-blind, parallel-group comparison study of 8-12 weeks of treatment with vitamin E (1600 IU/day) or matching placebo capsules. RESULTS: The Abnormal Involuntary Movement Scale scores of the patients treated with vitamin E improved significantly compared to the scores of the patients given placebo. CONCLUSIONS: These results support earlier findings of the efficacy of vitamin E in treating tardive dyskinesia.


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
N. Maruoka, T. Murata, N. Omata, Y. Takashima, Y. Fujibayashi, and Y. Wada
Effects of vitamin E supplementation on plasma membrane permeabilization and fluidization induced by chlorpromazine in the rat brain
J Psychopharmacol, March 1, 2008; 22(2): 119 - 127.
[Abstract] [PDF]


Home page
The Annals of PharmacotherapyHome page
D. Q Pham and R. Plakogiannis
Vitamin E Supplementation in Alzheimer's Disease, Parkinson's Disease, Tardive Dyskinesia, and Cataract: Part 2
Ann. Pharmacother., December 1, 2005; 39(12): 2065 - 2071.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
E. Shamir, Y. Barak, I. Shalman, M. Laudon, N. Zisapel, R. Tarrasch, A. Elizur, and R. Weizman
Melatonin Treatment for Tardive Dyskinesia: A Double-blind, Placebo-Controlled, Crossover Study
Arch Gen Psychiatry, November 1, 2001; 58(11): 1049 - 1052.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
G. Tsai, D. C. Goff, R. W. Chang, J. Flood, L. Baer, and J. T. Coyle
Markers of Glutamatergic Neurotransmission and Oxidative Stress Associated With Tardive Dyskinesia
Am J Psychiatry, September 1, 1998; 155(9): 1207 - 1213.
[Abstract] [Full Text]


Home page
J PsychopharmacolHome page
S.M. Dursun, O.J. Oluboka, S. Devarajan, and S.P. Kutcher
High-dose vitamin E plus vitamin B6 treatment of risperidone-related neuroleptic malignant syndrome
J Psychopharmacol, January 1, 1998; 12(2): 220 - 221.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1993 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org